Body mass index in dementia |
|
Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor |
|
CAIDE Dementia Risk Score and biomarkers of neurodegeneration in memory clinic patients without dementia |
|
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival |
|
CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients |
|
Dementia and obesity paradox: reply to the letter by Dr. Moga et al. |
|
DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE IN SPECIALIST UNITS COMPARED TO PRIMARY CARE |
|
Diagnosis of Dementia in the Specialist Setting: A Comparison Between the Swedish Dementia Registry (SveDem) and the Registry of Dementias of Girona (ReDeGi). |
|
Differences in drug therapy between dementia disorders in the Swedish dementia registry: a nationwide study of over 7,000 patients |
|
Differences in routine clinical practice between early and late onset Alzheimer's disease: data from the Swedish Dementia Registry (SveDem). |
|
Differential CSF biomarker levels in APOE-epsilon4-positive and -negative patients with memory impairment. |
|
Do adapted vignettes improve medical decision-making capacity for individuals with Alzheimer's disease? |
|
Does Fatty Acid Composition in Subcutaneous Adipose Tissue Differ between Patients with Alzheimer's Disease and Cohabiting Proxies? |
|
Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting. |
|
Early-Onset Dementia: Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers. |
|
The Effect of Age Correction on Multivariate Classification in Alzheimer's Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects |
|
The effects of different familial Alzheimer's disease mutations on APP processing in vivo |
|
Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study |
|
Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial. |
|
Glutamic acid decarboxylase- and peptide-immunoreactive neurons in cortex cerebri following development in isolation: evidence of homotypic and disturbed patterns in intraocular grafts. |
|
Heart failure and dementia: survival in relation to types of heart failure and different dementia disorders |
|
Identifying patients at high and low risk of cognitive decline using Rey Auditory Verbal Learning Test among middle-aged memory clinic outpatients. |
|
The Impact of Antipsychotic Drugs on Long-term Care, Nursing Home Admission and Death among Dementia Patients |
|
In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients. |
|
Incidence, clinical features and subtypes of delirium in elderly patients treated for hip fractures |
|
Increasing CSF phospho-tau levels during cognitive decline and progression to dementia. |
|
Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease. |
|
Intracerebroventricular infusion of nerve growth factor induces pain-like response in rats |
|
Investigating medical decision-making capacity in patients with cognitive impairment using a protocol based on linguistic features. |
|
Lack of accuracy for the proposed 'Dubois criteria' in Alzheimer's disease: a validation study from the Swedish brain power initiative. |
|
Laminin immunohistochemistry: a simple method to visualize and quantitate vascular structures in the mammalian brain. |
|
Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients |
|
Management of acute ischaemic stroke in patients with dementia |
|
The meaning of living close to a person with Alzheimer disease |
|
Medial temporal lobe atrophy and depressive symptoms in elderly patients with and without Alzheimer disease. |
|
Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review |
|
Modern dementia care on the rise thanks to national guidelines |
|
Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid |
|
Morphological and electrophysiological studies of human hippocampal transplants in the anterior eye chamber of athymic nude rats |
|
Mortality risk after dementia diagnosis by dementia type and underlying factors: a cohort of 15,209 patients based on the Swedish Dementia Registry |
|
Nerve growth factor can influence growth of cortex cerebri and hippocampus: Evidence from intraocular grafts |
|
The nerve growth factor receptor gene is expressed in both neuronal and non-neuronal tissues in the human fetus |
|
Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers |
|
Omega-3-fatty acids protect against dementia. Also early symptoms of mild Alzheimer disease seem to be inhibited |
|
Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. |
|
On intrinsic and extrinsic determinants of brain development and aging : structural and functional studies with special reference to intraocular brain tissue transplants |
|
Overall and domain-specific life satisfaction when living with familial Alzheimer's disease risk: A quantitative approach. |
|
Postoperative delirium in elderly patients after major abdominal surgery. |
|
Pre-operative mild cognitive dysfunction predicts risk for post-operative delirium after elective cardiac surgery. |
|
Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease. |
|
Prescription Changes During Geriatric Care Episodes: A Trend Analysis Conducted in Sweden. |
|
Progression of Alzheimer disease in Europe: data from the European ICTUS study. |
|
Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study. |
|
Relatives' experiences of encountering the older person with acute confusional state: experiencing unfamiliarity in a familiar person. |
|
Resolution of inflammation is altered in Alzheimer's disease |
|
Response to Bogaiksy's letter to the editor. |
|
Role of growth factors in degeneration and regeneration in the central nervous system; clinical experiences with NGF in Parkinson's and Alzheimer's diseases. |
|
Spatial distributions of cytoskeletal proteins and the nerve growth factor receptor in septal transplants in oculo: protection from abnormal immunoreactivity by hippocampal co-grafts. |
|
Structural and neurochemical effects in mouse cerebellum following neonatal methylazoxymethanol and 6-hydroxydopamine treatment |
|
Subjective cognitive impairment subjects in our clinical practice |
|
Targeting Alzheimer's Disease with Gene and Cell Therapies. |
|
Testicular atrophy and loss of nerve growth factor-immunoreactive germ cell line in rats exposed to n-hexane and a protective effect of simultaneous exposure to toluene or xylene. |
|
Toluene exposure during maturation of intraocular brain tissue transplants: Alterations of host and graft cerebellar Purkinje neuron function and sensitivity to norepinephrine |
|
Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study. |
|
Treatment of Atrial Fibrillation in Patients with Dementia: A Cohort Study from the Swedish Dementia Registry. |
|
The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey. |
|
The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease |
|
The use of MRI, CT and lumbar puncture in dementia diagnostics: data from the SveDem Registry |
|